Drug intelligence / Profile preview

SSS06 (3SBio)

Development stage: Unknown
Lead developer: Shenyang Sunshine Pharmaceuticals
Modality: Recombinant Proteins and Enzymes
Administration: Intravenous, Subcutaneous

Overview

SSS06 is a long-acting recombinant erythropoiesis-stimulating protein (rESP) developed by Shenyang Sunshine Pharmaceutical (3SBio). It is a biologic therapeutic designed to treat anemia in patients with chronic kidney disease, particularly those undergoing hemodialysis. SSS06 is a modified version of erythropoietin, containing 165 amino acids with three additional glycosylation sites engineered to extend its half-life compared to standard epoetin alfa. It acts as an agonist for the erythropoietin receptor, stimulating the production of red blood cells in the bone marrow. In clinical trials, SSS06 has been evaluated for maintenance therapy of anemia in hemodialysis patients, demonstrating non-inferiority to standard epoetin alfa treatments.

Other names: Recombinant Erythropoiesis Stimulating Protein InjectionHuman Erythropoiesis InjectionRecombinant Erythropoiesis Stimulating Protein Injection (CHO cell)Human Erythropoiesis Injection (CHO cell)

Targets

Erythropoietin Receptor

Beyond the preview

Go deeper on SSS06 (3SBio).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SSS06 (3SBio).

Explore the full profile